Geneos Wealth Management’s Vericel VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-101
Closed -$4.49K – 3237
2026
Q2
$4.49K Sell
101
-296
-75% -$10.7K ﹤0.01% 2208
2026
Q1
$12.8K Buy
+397
New +$14.1K ﹤0.01% 1918
2025
Q4
– Sell
-580
Closed -$18.3K – 2563
2025
Q3
$18.3K Sell
580
-1,355
-70% -$48.7K ﹤0.01% 1752
2025
Q2
$82.3K Sell
1,935
-385
-17% -$16K ﹤0.01% 1328
2025
Q1
$104K Sell
2,320
-191
-8% -$10.3K ﹤0.01% 1151
2024
Q4
$138K Buy
2,511
+2,240
+827% +$113K ﹤0.01% 961
2024
Q3
$11.4K Sell
271
-1,969
-88% -$93.7K ﹤0.01% 1787
2024
Q2
$103K Hold
2,240
– – ﹤0.01% 862
2024
Q1
$117K Hold
2,240
– – 0.01% 813
2023
Q4
$79.8K Hold
2,240
– – ﹤0.01% 904
2023
Q3
$75.1K Hold
2,240
– – ﹤0.01% 959
2023
Q2
$84.2K Buy
+2,240
New +$73.6K ﹤0.01% 926
2022
Q1
– Sell
-2,240
Closed -$88K – 2992
2021
Q4
$88K Hold
2,240
– – ﹤0.01% 1221
2021
Q3
$112K Hold
2,240
– – ﹤0.01% 1128
2021
Q2
$115K Hold
2,240
– – ﹤0.01% 1115
2021
Q1
$139K Hold
2,240
– – ﹤0.01% 1148
2020
Q4
$124K Hold
2,240
– – 0.01% 1043
2020
Q3
$40K Hold
2,240
– – ﹤0.01% 1353
2020
Q2
$29K Buy
2,240
+1,000
+81% +$13.5K ﹤0.01% 1461
2020
Q1
$11K Hold
1,240
– – ﹤0.01% 1791
2019
Q4
$21K Hold
1,240
– – ﹤0.01% 1674
2019
Q3
$18K Sell
1,240
-7
-0.6% -$122 ﹤0.01% 1662
2019
Q2
$23K Hold
1,247
– – ﹤0.01% 1572
2019
Q1
$21K Hold
1,247
– – ﹤0.01% 1552
2018
Q4
$21K Hold
1,247
– – ﹤0.01% 1491
2018
Q3
$17K Hold
1,247
– – ﹤0.01% 1662
2018
Q2
$12K Buy
+1,247
New +$15.5K ﹤0.01% 1656

Other funds holding VCEL

Geneos Wealth Management's VCEL Position: Q3 2026 in Review

Geneos Wealth Management sold out of Vericel (VCEL) in Q3 2026, closing a stake of 101 shares — an estimated $4.49K sold.

Geneos Wealth Management first reported a position in VCEL in Q2 2018 and held it in 27 quarters. The position peaked at $139K in Q1 2021. 320 funds tracked by Wall St. Rank hold VCEL as of Q3 2026.

  • Geneos Wealth Management reported no remaining Vericel position as of Q3 2026 after selling out during the quarter.
  • Geneos Wealth Management sold 101 Vericel shares in Q3 2026, an estimated $4.49K.
  • Geneos Wealth Management first reported a position in Vericel in Q2 2018 and held it in 27 quarters.
  • Geneos Wealth Management's Vericel position peaked at $139K in Q1 2021.
  • 320 funds tracked by Wall St. Rank held Vericel as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.